Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2025-12-26 @ 3:28 AM
Study NCT ID:
NCT04281420
Status:
TERMINATED
Last Update Posted:
2024-04-30
First Post:
2020-02-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Sponsor:
Antengene Therapeutics Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-13
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-02
Completion Date Type:
ACTUAL
First Submit Date:
2020-02-18
First Submit QC Date:
None
Study First Post Date:
2020-02-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-27
Last Update Post Date:
2024-04-30
Last Update Post Date Type:
ACTUAL